Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |